Qianhong Bio-pharma: The net profit for the third quarter was 125 million yuan, a year-on-year decrease of 1.28%Zhitong·Oct 29, 2025 at 07:16 AM002550+0.15%
Qianhong Bio-pharma: Warned for failing to disclose and halt trading in a timely manner when the shareholding ratio reached the 25% thresholdZhitong·Sep 12, 2025 at 03:08 AM002550+0.15%
Qianhong Bio-pharma released its performance for the first half of the year, with a net profit attributable to the parent company of 258 million yuan, an increase of 41.17%Zhitong·Aug 22, 2025 at 04:40 AM002550+0.15%
Qianhong Bio-pharma shareholder Zhao Gang and his concerted actors plan to reduce their holdings by no more than 20.9 million sharesZhitong·Aug 6, 2025 at 06:39 AM002550+0.15%
The concept of innovative drugs fluctuates and rebounds, ALK hits the limit and reaches a historical highZhitong·Jul 18, 2025 at 12:50 AM002940+3.97%002550+0.15%
Qianhong Bio-pharma hit the daily limit and achieved 2 consecutive trading limits, with a cumulative increase of 20.99% over 2 daysZhitong·Jul 17, 2025 at 01:55 AM002550+0.15%
July 16th Midday Review: The ChiNext Index rose 0.36% in half a day, and robotics concept stocks strengthened againWallstreetcn·Jul 15, 2025 at 10:30 PM002550+0.15%688585+14.97%
The innovative drug concept has repeatedly strengthened, and Qianhong Bio-pharma has surged to the limit36Kr·Jul 9, 2025 at 09:16 PM688799+3.19%603716+3.38%
Qianhong Bio-pharma shareholder Wang Ke has completed the increase in holdings, accumulating a 1.72% stakeZhitong·Jun 25, 2025 at 03:23 AM002550+0.15%
Qianhong Bio-pharma conducted a block trade today at par, with 9.2 million shares traded and a transaction amount of 82.064 million yuanZhitong·Jun 24, 2025 at 03:50 AM002550+0.15%
Qianhong Bio-pharma received a 0.75% share increase from shareholder Wang KeZhitong·Jun 19, 2025 at 06:23 AM002550+0.15%
The innovative drug concept fell at the beginning of the session, with Cosunter down 10%Zhitong·Jun 17, 2025 at 08:28 PM002550+0.15%000788+1.36%
The three major indices of A-shares in Shanghai and Shenzhen opened with narrow differentiation, and some innovative drug concept stocks continued to riseAASTOCKS·Jun 9, 2025 at 08:29 PM300584+1.41%002550+0.15%
Qianhong Bio-pharma released its 2024 annual performance, with a net profit attributable to the parent company of 356 million yuan, an increase of 95.77%Zhitong·Apr 18, 2025 at 04:13 AM002550+0.15%
